Search

This study sought to determine the relationship among broiler performance, organ development, and indicators of microbiota colonization. A total of 1,200 two-day-old male Ross 308 broiler chicks, divided among 3 cohorts of equal size, were housed in battery cages, and allotted based on body weight. On study d 11, birds were weighed, and birds with BW gain within the 10th and 90th percentiles were assigned to the Slow and Fast groups, respectively. Birds (n = 30 for each group) selected on d 11 were provided water and a corn-soybean meal-based diet ad libitum while maintained individually through study d 25 (i.e., a 14-d growth period). Parameters regarding growth performance, organ and intestine weights and lengths, and intestinal volatile fatty acid concentrations were measured. All data were analyzed by one-way ANOVA using the Mixed procedure of SAS. Fast birds exhibited greater (P< 0.001) BW gain and feed intake than slow birds, but feed conversion ratio (FCR) did not differ (P= 0.19). Additionally, Slow birds had higher (P< 0.05) relative weights (% of BW) for nearly all organs on d 11 and 25, most notably the gizzard, proventriculus, pancreas, and liver. Conversely, intestinal sections were longer (P< 0.05) in the Fast birds. Measurement of gut histomorphology did not show any notable differences between growth rate groups in terms of villi height, crypt depth, or their ratio for either time-point (P> 0.05). In terms of volatile fatty acid concentrations of luminal contents, acetate concentrations were 10.2% higher (P< 0.001) in the ileum of the Slow birds compared with Fast birds on d 25. Overall, the findings suggest that total BW gain is influenced by the development of metabolically active organs, as supported by lower weight gain in Slow birds with relatively larger organ weights and shorter intestinal lengths than their Fast counterparts. The general lack of differences in fermentation end-product concentrations in luminal contents does not rule out influence of the microbiota on growth rate of broilers, which warrants further investigation.

This experiment was conducted to evaluate the effects of dietary supplementation level of probiotics on growth performance, blood variables, and fecal metabolites in nursery pigs. Certain strains of Bacillus subtilishave been shown to reduce the incidence and severity of diarrhea and therefore improve growth performance of nursery pigs. A total of 54 newly weaned piglets were allotted to 3 treatments in 3 replicates with 6 pigs per pen based on body weight, gender, and breed for a 28-d feeding trial. Treatments were: 1) Control: no probiotics supplementation, 2) CERTILLUS 1x: probiotics supplementation at the recommended level, and 3) CERTILLUS 10x: probiotics supplementation at 10 times the recommended level. The CERTILLUS products consisted of two strains of Bacillus subtilis at a low and a high dose of 3.75 × 108CFU/g and 3.75 × 109CFU/g supplemented at 0.05% resulting in 1.875 × 105CFU/g diet and 1.875 × 106CFU/g diet for the 1x and 10x treatments, respectively. Corn-soybean meal-based diets were used for d 0-14 (Phase 1) and d 14-28 (Phase 2) postweaning. Body weight, blood glucose and creatinine, fecal short chain fatty acid (SCFA) and bile acid concentrations were measured at d 14 and 28 postweaning. Body weight at d 14 postweaning (P= 0.06; 11.98, 12.73, and 12.21 kg for the control, 1x, and 10x treatments, respectively) and average daily gain for d 0 to 14 postweaning (P< 0.05; 0.206, 0.259, and 0.222 kg/d, respectively) were greater in the 1x treatment than the control and 10x treatments although there was no significant difference in growth performance at d 28 postweaning. Blood glucose concentrations were greater in both probiotic treatments than the control treatment at d 14 postweaning (P< 0.05; 95.2, 111.7 and 114.3 mg/dL for the control, 1x, and 10x treatments, respectively). In the fecal SCFA concentrations, the butyrate concentrations were greater in the 1x treatment than the control and 10x treatments (P< 0.05; 36.17, 47.57, and 33.23 µmol/g feces for the control, 1x, and 10x treatments, respectively) and the acetate (120.02, 141.87, and 101.17 µmol/g feces, respectively), propionate (62.95, 71.42 and 55.27 µmol/g feces, respectively), and total SCFA (236.72, 282.23, and 205.80 µmol/g feces, respectively) concentrations were greater in the 1x treatment than the 10x treatment with the intermediate value in the control treatment (P< 0.05). There were no significant differences in fecal bile acid concentrations and blood creatinine concentrations at both d 14 and 28 postweaning. In conclusion, dietary probiotics supplementation to nursery diets at the recommended level could improve growth rate in the early postweaning period and increase fecal SCFA concentrations but not at a high level of supplementation.

In the first study, an in vitroculture system was developed to investigate the effects of carnosine on macrophage proinflammatory cytokine response using an established chicken macrophage cell line (CMC), gut integrity using a chicken intestinal epithelial cell line (IEC), muscle differentiation in quail muscle cells (QMCs) and primary chicken embryonic muscle cells (PMCs), and direct anti-parasitic effect against Eimeria maximasporozoites. Cells to be tested were seeded in 24-well plates and treated with carnosine at 4 different concentrations (0.1, 1.0, and 10.0 µg). After 18 h of incubation, cells were harvested to measure gene expression of proinflammatory cytokines in CMC, tight junction (TJ) proteins in IECs, and muscle cell growth markers in QMCs and PMCs. In vivotrials were conducted to investigate the effect of dietary carnosine on disease parameters in broiler chickens challenged with E. maxima. One hundred and twenty male broiler chickens (0-day-old) were allocated into four treatment groups: (1) basal diet without infection (NC), (2) basal diet with E. maximainfection (PC), (3) carnosine at 10.0 mg/kg feed with PC (HCS), and (4) carnosine at 1.0 mg/kg feed with PC (LCS). All groups except NC were orally infected with E. maximaon day 14. Jejunal samples were collected for lesion scoring and jejunum gut tissues were used for transcriptomic analysis of cytokines and TJ proteins. In vitro, carnosine treatment significantly decreased IL-1β gene expression in CMC following LPS stimulation. In vivofeeding studies showed that dietary carnosine increased BW and ADG of chickens in E. maxima-infected groups and reduced the jejunal lesion score and fecal oocyst shedding in HCS group. Jejunal IL-1β, IL-8, and IFN-γ expression were suppressed in the HCS group compared to PC. The expression levels of claudin-1 and occludin in IECs were also increased in HCS following carnosine treatment. In conclusion, these findings highlight the beneficial effects of dietary carnosine supplementation on intestinal immune responses and gut barrier function in broiler chickens exposed to E. maximainfection.

Molecular characterization of avian pathogenic Escherichia coli(APEC) is challenging due to the complex nature of its associated disease, colibacillosis, in poultry. Numerous efforts have been made toward defining APEC, and it is becoming clear that certain clonal backgrounds are predictive of an avian E. coliisolate's virulence potential. Thus, APEC can be further differentiated as high-risk APEC based upon their clonal background's virulence potential. However, less clear is the degrees of overlap between clinical isolates of differing bird type, and between clinical and gastrointestinal isolates. This study aimed to determine genomic similarities and differences between such populations, comparing commercial broiler vs. turkey isolates, and clinical vs. gastrointestinal isolates. Differences were observed in Clermont phylogenetic groups between isolate populations, with B2 as the dominant group in turkey clinical isolates and G as the dominant group in broiler clinical isolates. Nearly all clinical isolates were classified as APEC using a traditional gene-based typing scheme, whereas 53.4% and 44.1% of broiler and turkey gastrointestinal isolates were classified as APEC, respectively. High-risk APEC were identified among 31.0% and 46.9% of broiler and turkey clinical isolates, compared with 5.7% and 2.9% of broiler and turkey gastrointestinal isolates. As found in previous studies, no specific known virulence or fitness gene sets were identified which universally differentiate between clinical and gastrointestinal isolates. This study further demonstrates the utility of a hybrid APEC typing approach, considering both plasmid content and clonal background, for the identification of dominant and highly virulent APEC clones in poultry production.